Ozempic, Rybelsus and Wegovy join round two of Medicare price talks in 2027

More peptides

1. GLP-1 obesity drug sales value rose 72% in September 2026 as units fell 10%

   FFacebook Oct 30

   peptides typeshitPrices

   GLP-1 obesity drug sales value rose 72% in September 2026 as units fell 10%

   New generics and steady prices drove the jump in sales value, with Eli Lilly's tirzepatide leading the market.

   See it on Facebook
2. Fewer US employees will get GLP-1 weight loss drugs covered at work

   BBloomberg Oct 30

   peptides typeshitPrices

   Fewer US employees will get GLP-1 weight loss drugs covered at work

   Bloomberg reports that employer coverage of GLP-1 weight loss drugs is shrinking, leaving fewer US workers with access through their health plans.

   Read at Bloomberg
3. UBS lifts its Eli Lilly price target to $1,625 on obesity drug demand

   YFYahoo Finance Oct 30

   peptides typeshitPrices

   UBS lifts its Eli Lilly price target to $1,625 on obesity drug demand

   UBS says volumes grew about 55% while net prices fell roughly 14%, and points to about 500,000 people joining Lilly's Medicare bridge program in a few months.

   Read at Yahoo Finance
4. Weight loss market forecast to reach $244 billion by 2036, led by GLP-1 drugs

   YFYahoo Finance Oct 30

   peptides typeshitPrices

   Weight loss market forecast to reach $244 billion by 2036, led by GLP-1 drugs

   A new market report values the sector at $97.5 billion in 2025 and expects oral and multi-pathway drugs to grow fastest as Medicare coverage starts in mid-2026.

   Read at Yahoo Finance
5. Reddit ELI5 thread asks why people take peptides in the first place

   RReddit Oct 31

   peptides typeshitNews

   Reddit ELI5 thread asks why people take peptides in the first place

   A beginner question asking for a simple explanation of why people use peptides. There's no news here, just an open discussion thread.

   Read on Reddit
6. Richard Norton's death in Victoria linked to a double dose of peptides

   ?شبكة تواصل الإخبارية Oct 31

   peptides typeshitSafety

   Richard Norton's death in Victoria linked to a double dose of peptides

   A report ties the Australian actor's death to taking twice the intended amount of a peptide. Details on the coroner's findings are in the full story.

   Read at شبكة تواصل الإخبارية